Cofoe Medical Technology Co., Ltd. (COFOE MEDICAL) released its Monthly Return for the period ended 31 May 2026, showing no changes to authorised, registered or issued share capital following the company’s H-share debut on the Main Board of the Hong Kong Stock Exchange on 6 May 2026.

Total authorised and registered share capital remained at RMB 235.90 million, split between 27.00 million H shares and 208.90 million A shares, each with a par value of RMB 1.

Issued share capital was also unchanged. The Hong Kong-listed H-share tranche closed the month with 27.00 million shares in issue and no treasury shares. The Shenzhen-listed A-share tranche maintained 208.90 million shares in issue, of which 7.20 million are held in treasury, leaving 201.70 million A shares outstanding.

COFOE MEDICAL confirmed compliance with the Hong Kong Exchange’s minimum public-float requirement, which for PRC issuers is 5% of outstanding H shares.

Under the share-option scheme approved on 21 March 2024, the company reported 4.48 million unexercised options outstanding, unchanged from the prior month; no new shares were issued and no treasury shares were transferred during May.

The company reported no warrants, convertible securities, or other equity-linked instruments outstanding, and noted no additional share movements during the month.